Clinical Trial Update: Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating a paracetamol + phenylephrine + guaifenesin syrup for upper respiratory tract infection, focusing on warming sensation, flavor a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Respiratory Tract Infection

Drugs mentioned

• Guaifenesin (guaifenesin)
• Paracetamol (acetaminophen)
• Phenylephrine (phenylephrine)

Snippet

Sponsor: Novartis | Conditions: Upper Respiratory Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-11-11